Broadly Neutralizing Antibody Therapy for HIV-1 Treatment and Long-Term Viral Remission
2026 | IDOSR JOURNAL OF BIOLOGY, CHEMISTRY AND PHARMACY | Pp. 99-105
Human immunodeficiency virus type 1 (HIV-1) infection affected approximately 38 million individuals globally, with lifelong antiretroviral therapy required to suppress viral replication. Despite effective viral suppression, antiretroviral therapy does not era...